Goodrx Holdings Inc
NASDAQ:GDRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/OCF
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Valuation Scenarios
If P/OCF returns to its 3-Year Average (13), the stock would be worth $6.41 (177% upside from current price).
| Scenario | P/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 4.7 | $2.31 |
0%
|
| 3-Year Average | 13 | $6.41 |
+177%
|
| 5-Year Average | 16 | $7.87 |
+241%
|
| Industry Average | 16.1 | $7.91 |
+242%
|
| Country Average | 13.3 | $6.57 |
+184%
|
Forward P/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | P/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
787.8m USD | 4.7 | 25.9 | |
| JP |
|
Medical Data Vision Co Ltd
TSE:3902
|
37.9T JPY | 81.5 | 227.5 | |
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD | 18.4 | 53.1 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
26.4B USD | 18.6 | 29 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
14.5B AUD | 111.4 | 60.7 | |
| JP |
|
M3 Inc
TSE:2413
|
1T JPY | 15.8 | 20.5 | |
| SE |
|
Sectra AB
STO:SECT B
|
51.8B SEK | 63.3 | 94.2 | |
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.9B USD | 15.4 | 42.4 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.4B USD | 14.1 | 18.6 | |
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
18.7B CNY | 37.4 | -60.8 | |
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR | 64.1 | -328 |
Market Distribution
| Min | 0 |
| 30th Percentile | 8.8 |
| Median | 13.3 |
| 70th Percentile | 20.1 |
| Max | 3 188 432.5 |
Other Multiples
Goodrx Holdings Inc
Glance View
GoodRx Holdings Inc., established at the intersection of healthcare and technology, has carved a niche in the American pharmaceutical industry by addressing one of its most notorious challenges: the high cost of prescription medications. Originally founded in 2011, GoodRx aims to ease the financial burden of medication costs for consumers by providing a platform that aggregates drug pricing information from pharmacies across the United States. By doing so, it empowers users to compare prices, identify potential savings, and subsequently make informed decisions about their medication purchases. At its core, GoodRx operates as a digital intermediary; its app and website seamlessly connect consumers with discounted prescription offers through partnerships with pharmacy benefit managers (PBMs) and retail pharmacies. The company's revenue model is primarily built on a commission and advertising framework. When users select a coupon from GoodRx and purchase at a pharmacy, the company receives a fee from its pharmacy partners or PBMs. Additionally, GoodRx leverages its vast user base, which is largely driven by organic traffic resulting from the essential nature of its service, to generate advertising revenues from pharmaceutical companies and other health-related entities eager to reach consumers actively seeking medication solutions. By continually expanding its services, such as telehealth offerings and a subscription model called GoodRx Gold, the company seeks to deepen its integration into the consumer healthcare experience while maintaining its core mission of providing accessible and affordable medication options.